Study Site — Atlanta, Georgia

Study Site is a clinical research site located in Atlanta, Georgia, United States 30301.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Study Site has participated in 10 clinical trials.

Therapeutic areas: Type 2 Diabetes, Primary Immune Deficiency, Food Allergy.

Sponsors: Better Therapeutics, CSL Behring, Alladapt Immunotherapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site?

Study Site has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site conducted?

Study Site has 10 clinical trials on record. Their work covers Type 2 Diabetes, Primary Immune Deficiency, Food Allergy.

Is Study Site accredited by Crixeo Health?

Yes — Study Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.